IL-13 as a novel growth factor in CTCL

Blood

Volumn 125, Issue 18, 2015, Pages 2737-2738

  Wasik, Mariusz A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 26; INTERLEUKIN 32; INTERLEUKIN 4; NEUTRALIZING ANTIBODY; STAT6 PROTEIN;

CELL PROLIFERATION; CUTANEOUS T CELL LYMPHOMA; ERYTHRODERMA; IN VITRO STUDY; MYCOSIS FUNGOIDES; NOTE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEZARY SYNDROME; FEMALE; HUMAN; MALE; METABOLISM; PATHOLOGY;

CELL PROLIFERATION; FEMALE; HUMANS; INTERLEUKIN-13; LYMPHOMA, T-CELL, CUTANEOUS; MALE;

EID: 84929493793     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2015-02-626432     Document Type: Note

References (10)

1. Geskin LJ, Viragova S, Stolz DB, Fuschiotti P. Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation. Blood. 2015;125(18):2798-2805.
2. Vaqué JP, Gómez-López G, Monsálvez V, et al. PLCG1 mutations in cutaneous T-cell lymphomas. Blood. 2014;123(13):2034-2043.
3. Zhang Q, Nowak I, Vonderheid EC, et al. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome. Proc Natl Acad Sci USA. 1996;93(17):9148-9153.
4. Abraham RM, Zhang Q, Odum N, Wasik MA. The role of cytokine signaling in the pathogenesis of cutaneous T-cell lymphoma. Cancer Biol Ther. 2011;12(12): 1019-1022.
5. Netchiporouk E, Litvinov IV, Moreau L, Gilbert M, Sasseville D, Duvic M. Deregulation in STAT signaling is important for cutaneous T-cell lymphoma (CTCL) pathogenesis and cancer progression. Cell Cycle. 2014; 13(21):3331-3335.
6. Willerslev-Olsen A, Litvinov IV, Fredholm SM, et al. IL-15 and IL-17F are differentially regulated and expressed in mycosis fungoides (MF). Cell Cycle. 2014; 13(8):1306-1312.
7. Wolk K, Mitsui H, Witte K, et al. Deficient cutaneous antibacterial competence in cutaneous T-cell lymphomas: role of Th2-mediated biased Th17 function. Clin Cancer Res. 2014;20(21):5507-5516.
8. Ohmatsu H, Humme D, Gulati N, et al. IL32 is progressively expressed in mycosis fungoides independent of helper T-cell 2 and helper T-cell 9 polarization. Cancer Immunol Res. 2014;2(9):890-900.
9. Singer EM, Shin DB, Nattkemper LA, et al. IL-31 is produced by the malignant T-cell population in cutaneous T-cell lymphoma and correlates with CTCL pruritus. J Invest Dermatol. 2013;133(12):2783-2785.
10. Guenova E, Watanabe R, Teague JE, et al. TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphoma. Clin Cancer Res. 2013;19(14):3755-3763.